[1] |
Rizvi S, Khan SA, Hallemeier CL, et al. Cholangiocarcinoma - evolving concepts and therapeutic strategies[J]. Nat Rev Clin Oncol, 2018, 15(2):95-111.
|
[2] |
Zhang H, Yang T, Wu M, et al. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management[J]. Cancer Lett, 2016, 379(2):198-205.
doi: 10.1016/j.canlet.2015.09.008
pmid: 26409434
|
[3] |
Benson AB, D′Angelica MI, Abbott DE, et al. Guidelines insights: hepatobiliary cancers, version 2.2019[J]. J Natl Compr Canc Netw, 2019, 17(4):302-310.
|
[4] |
科技部传染病重大专项课题“病毒性肝炎相关肝癌外科综合治疗的个体化和新策略研究”专家组. 肝内胆管癌外科治疗中国专家共识(2020版)[J]. 中华消化外科杂志, 2021, 20(1):1-15.
|
[5] |
梁后杰, 秦叔逵, 沈锋, 等. CSCO胆道系统肿瘤诊断治疗专家共识(2019年版)[J]. 临床肿瘤学杂志, 2019, 24(9):828-838.
|
[6] |
Zhang X, Li J, Shen F, et al. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2018, 33(2):347-354.
|
[7] |
Doussot A, Lim C, Gómez-Gavara C, et al. Multicentre study of the impact of morbidity on long-term survival following hepatectomy for intrahepatic cholangiocarcinoma[J]. Br J Surg, 2016, 103(13):1887-1894.
doi: 10.1002/bjs.10296
pmid: 27629502
|
[8] |
Rodríguez-Perálvarez M, Luong TV, Andreana L, et al. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability[J]. Ann Surg Oncol, 2013, 20(1):325-339.
doi: 10.1245/s10434-012-2513-1
pmid: 23149850
|
[9] |
Li MX, Bi XY, Li ZY, et al. Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis[J]. J Surg Res, 2016, 203(1):163-173.
|
[10] |
Ribero D, Pinna AD, Guglielmi A, et al. Surgical approach for longterm survival of patients with intrahepatic cholangiocarcinoma: a multiinstitutional analysis of 434 patients[J]. Arch Surg, 2012, 147(12):1107-1113.
doi: 10.1001/archsurg.2012.1962
pmid: 22910846
|
[11] |
Farges O, Fuks D, Boleslawski E, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group[J]. Ann Surg,2011, 254(5):824-829.
|
[12] |
Watanabe Y, Matsuyama Y, Izumi N, et al. Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: a nationwide survey of the Liver Cancer Study Group of Japan[J]. Surgery, 2020, 167(5):793-802.
|
[13] |
Mavros MN, Economopoulos KP, Alexiou VG, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis[J]. JAMA Surg, 2014, 149(6):565-574.
|
[14] |
Zhang XF, Xue F, Dong DH, et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis[J]. Ann Surg,2020-01-14.doi: 10.1097/SLA.0000000000003788.[online ahead of print].
doi: 10.1097/SLA.0000000000003788.[online ahead of print]
URL
|
[15] |
Spolverato G, Kim Y, Ejaz A, et al. Conditional probabi-lity of longterm survival after liver resection for intrahe-patic cholangiocarcinoma: a multi-institutional analysis of 535 patients[J]. JAMA Surg, 2015, 150(6):538-545.
doi: 10.1001/jamasurg.2015.0219
pmid: 25831462
|
[16] |
施杰毅, 高强, 周俭, 等. 第8版AJCC肝内胆管癌TNM分期的解读与验证[J]. 外科理论与实践, 2018, 23(3):221-226.
|
[17] |
Hu LS, Weiss M, Popescu I, et al. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma[J]. J Surg Oncol, 2019, 119(1):21-29.
|
[18] |
Tsilimigras DI, Sahara K, Wu L, et al. Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches[J]. JAMA Surg, 2020, 155(9):823-831.
|
[19] |
Tang Z, Liu WR, Zhou PY, et al. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma[J]. J Cancer, 2019, 10(22):5575-5584.
|
[20] |
曾永毅, 林自国, 刘红枝, 等. 微血管侵犯对肝内胆管癌根治性切除病人预后影响研究:基于多中心的倾向评分匹配分析[J]. 中国实用外科杂志, 2020, 40(6):695-702.
|
[21] |
Yang P, Si A, Yang J, et al. A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion[J]. Surgery, 2019, 165(4):721-730.
|
[22] |
张小晶, 王琳. 微血管侵犯在肝癌综合诊断与治疗中的临床意义[J]. 中华消化外科杂志, 2019, 18(4):336-341.
|
[23] |
Lei Z, Li J, Wu D, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria[J]. JAMA Surg, 2016, 151(4):356-363.
|
[24] |
Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma[J]. J Hepatol, 2019, 70(6):1133-1144.
|
[25] |
刘红枝, 林海涛, 林昭旺, 等. 机器学习算法在肝细胞癌微血管侵犯术前预测中的应用价值[J]. 中华消化外科杂志, 2020, 19(2):156-165.
|
[26] |
Reames BN, Ejaz A, Koerkamp BG, et al. Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis[J]. J Surg Oncol, 2017, 116(2):133-139.
|
[27] |
Conci S, Viganò L, Ercolani G, et al. Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma[J]. Eur J Surg Oncol, 2020, 46(9):1727-1733.
|
[28] |
Beal EW, Cloyd JM, Pawlik TM. Surgical treatment of intrahepatic cholangiocarcinoma: current and emerging principles[J]. J Clin Med, 2020, 10(1):104.
|
[29] |
Sheng X, Ji Y, Ren GP, et al. A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC[J]. Hepatol Int, 2020, 14(6):1034-1047.
doi: 10.1007/s12072-020-10111-4
pmid: 33369707
|